Changes in the brain's serotonin system may occur years before Parkinson's disease symptoms begin. Serotonin alterations could be used as a biomarker for Parkinson's disease.
CRISPR technology allows researchers to illuminate and monitor alpha synuclein in the brain.
Blocking the breakdown of a specific fat molecule in the the brains of mice lead to reduced learning ability and memory retention. Additionally, researchers noted an increase of Alzheimer's related proteins. Findings may help explain how dementia may develop in humans, researchers say.
Researchers have identified that mutations in the TMEM230 gene may be a cause of Parkinson's disease.
Using stem cells derived from Parkinson's patients, researchers confirm mitochondrial changes.
A new study investigates the effect of musical performance on the gene expression of professional musicians and finds enhanced activity in motor function, memory and learning.
